Source: ERJ Open Res, 5 (2) 00071-2019; 10.1183/23120541.00071-2019
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Jose M. Lorenzo-Salazar, Shwu-Fan Ma, Jonathan Jou, Pei-Chi Hou, Beatriz Guillen-Guio, Richard J. Allen, R. Gisli Jenkins, Louise V. Wain, Justin M. Oldham, Imre Noth, Carlos Flores. Novel idiopathic pulmonary fibrosis susceptibility variants revealed by deep sequencing. ERJ Open Res, 5 (2) 00071-2019; 10.1183/23120541.00071-2019

Member's Comments

No comment yet.

Related content which might interest you: Novel rare genetic variants in idiopathic pulmonary fibrosis Source: Eur Respir J, 56 (6) 2003252; 10.1183/13993003.03252-2020 Year: 2020 Combined idiopathic pulmonary fibrosis and emphysema: functional characterization Source: Eur Respir J 2004; 24: Suppl. 48, 283s Year: 2004 Genetic susceptibility and pulmonary fibrosis Source: Annual Congress 2005 - Idiopathic pulmonary fibrosis: new concepts in its pathogenesis and management Year: 2005 Accelerated variant of idiopathic pulmonary fibrosis: clinical and molecular behaviour Source: Eur Respir J 2007; 30: Suppl. 51, 488s Year: 2007 The genetic basis of idiopathic pulmonary fibrosis Source: Eur Respir J 2015; 45: 1717-1727 Year: 2015 Human exome analysis of candidate genetic variants for susceptibility to high-altitude pulmonary edema in Japanese Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement? Year: 2020 Polymorphism of the genes of xenobiothics detoxification in patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2004; 24: Suppl. 48, 536s Year: 2004 Potential new biomarkers for idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 PECAM-1 single nucleotide polymorphisms and idiopathic pulmonary fibrosis Source: Annual Congress 2011 - Lung development and neoplasia Year: 2011 Possible target genes in idiopathic pulmonary fibrosis Source: Annual Congress 2007 - PG9 - Molecular pathology and genetics in lung diseases Year: 2007 Transcriptome profiling reveals the complexity of pirfenidone effects in idiopathic pulmonary fibrosis Source: Eur Respir J, 52 (5) 1800564; 10.1183/13993003.00564-2018 Year: 2018 Combined pulmonary fibrosis and emphysema syndrome associated with ABCA3 mutations Source: Eur Respir J 2014; 43: 638-641 Year: 2013 Discovery and validation of peripheral blood gene expression profiles predictive of poor outcome and disease progression in idiopathic pulmonary fibrosis Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis Year: 2014 Association between AGTTGFB1ESR1, and VDR gene variants with idiopathic pulmonary fibrosis (IPF) and pulmonary sarcoidosis (PS) clinical features Source: International Congress 2017 – Functional genomics knowledge in parenchymal and bronchial diseases Year: 2017 Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms? Source: Eur Respir J 2007; 30: 835-839 Year: 2007 Pulmonary arteriole gene expression signature in idiopathic pulmonary fibrosis Source: Eur Respir J 2013; 41: 1324-1330 Year: 2013 Genetic polymorphisms in TNF genes and tuberculosis in cystic fibrosis patients Source: Annual Congress 2011 - Genetics of airway diseases and treatment Year: 2011 Functional and prognostic effects when emphysema complicates idiopathic pulmonary fibrosis Source: Eur Respir J, 50 (1) 1700379; 10.1183/13993003.00379-2017 Year: 2017 Idiopathic pulmonary upper lobe fibrosis shows distinct features and poor prognosis compared to idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013